Pharma Mar | PHM - Operating Profit


Pharma Mar reported EUR43.61M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Pharma Mar EUR 43.61M 47.57M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025